Archive · 25 Jun 2025
Abbott Launches Blood Test for Concussions, Speeding Diagnosis
Imagine you bump your head.
Doctors now have a quick blood test to see if your brain is hurt, like a mild bruise.
This new test gives results in minutes, faster than older tests, and can help doctors decide if you need a more detailed scan.
The test looks for special substances in your blood that show if your brain is injured.
This means less waiting at the hospital and fewer chances to be exposed to radiation, helping people feel better sooner.
Abbott has launched a lab-based blood test to evaluate concussions and mild traumatic brain injuries (mTBI).
The test provides results in 18 minutes to help clinicians quickly evaluate brain injury.
It can eliminate the need for CT scans by up to 40% with a high degree of certainty.
The test measures two biomarkers, UCH-L1 and GFAP, in the blood to assess brain injury.
The TBI test runs on Abbott's Alinity i and Architect i1000SR laboratory instruments.
- Who
- Abbott, a healthcare company.
- What
- Abbott launched a lab-based blood test to evaluate concussions or mild traumatic brain injuries.
- When
- The test was launched, with the news published on June 25, 2025.
- Where
- The test is available in major hospitals and laboratories.
- Why
- To quickly and accurately evaluate brain injuries, reduce the need for CT scans, and reduce wait times.
- Test Type
- Lab-based blood test
- Purpose
- Evaluate concussions and mTBI
- Result Time
- 18 minutes
- Biomarkers Measured
- UCH-L1 and GFAP
- CT Scan Reduction
- Up to 40%
- Instruments
- Alinity i and Architect i1000SR
- Company
- Abbott